Litcius/Paper detail

Contraception During Perimenopause: Practical Guidance

Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari, Fabio Facchinetti

2022International Journal of Women s Health17 citationsDOIOpen Access PDF

Abstract

Climacteric is by no means in itself a contraindication to safe contraception. On the contrary, there are several conditions related to the perimenopause that could benefit from the use of modern contraceptives, mainly hormonal, with the goals of avoiding unintended pregnancies and giving further possible benefits beyond contraception (menstrual cycle control, a reduction of vasomotor symptoms and menstrual migraines, a protection against bone loss, a positive oncological risk/benefit balance). This narrative review aims to provide practical guidance on their possible use in this particular life stage, both short- and long-acting reversible contraceptives, and to assist clinicians for women transitioning from contraception to their menopausal years, including the possible initiation of postmenopausal hormone therapy. Comprehensive contraceptive counselling is an essential aspect of the overall health and wellbeing of women and should be addressed with each such patient irrespective of age.

Topics & Concepts

MedicineFamily planningContraindicationGynecologyHormonal contraceptionPillMenopauseDeveloped countryClimactericPopulationAlternative medicineObstetricsNursingResearch methodologyInternal medicineEnvironmental healthPathologyReproductive Health and ContraceptionEndometriosis Research and TreatmentPregnancy and Medication Impact
Contraception During Perimenopause: Practical Guidance | Litcius